Clinical Trial Update: Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether different stem cell infusion times affect the incidence of acute graft-versus-host disease after umbilical cord blood …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Acute Graft Versus Host Disease | Phase 3 | Status: RECRUITING